Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 257,400 shares, a drop of 19.1% from the September 30th total of 318,100 shares. Based on an average daily trading volume, of 105,800 shares, the days-to-cover ratio is currently 2.4 days. Currently, 4.8% of the company’s shares are short sold.
Insider Transactions at Bullfrog AI
In other news, CEO Vininder Singh sold 14,405 shares of the company’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $2.65, for a total transaction of $38,173.25. Following the transaction, the chief executive officer now owns 2,478,041 shares in the company, valued at approximately $6,566,808.65. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 31,603 shares of company stock valued at $82,989 in the last quarter. 33.90% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Bullfrog AI
A number of hedge funds have recently bought and sold shares of BFRG. Fortem Financial Group LLC bought a new position in shares of Bullfrog AI during the first quarter valued at about $171,000. Renaissance Technologies LLC bought a new position in Bullfrog AI during the second quarter valued at $34,000. Finally, XTX Topco Ltd purchased a new stake in Bullfrog AI in the second quarter worth $32,000. 0.96% of the stock is owned by hedge funds and other institutional investors.
Bullfrog AI Stock Performance
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported ($0.20) earnings per share for the quarter.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Read More
- Five stocks we like better than Bullfrog AI
- Using the MarketBeat Stock Split Calculator
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What is the Hang Seng index?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Most Volatile Stocks, What Investors Need to Know
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.